Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -136.56 Million USD | -282.92% |
| 2022 | -65.21 Million USD | -65617.24% |
| 2021 | 58 Thousand USD | 100.27% |
| 2020 | -16.89 Million USD | -103.82% |
| 2019 | -10.51 Million USD | 13.68% |
| 2018 | -12.18 Million USD | -397.73% |
| 2017 | 8.09 Million USD | 21.1% |
| 2016 | 3.37 Million USD | 201.32% |
| 2015 | -3.33 Million USD | 64.07% |
| 2014 | -9.05 Million USD | -134.89% |
| 2013 | -3.95 Million USD | 24.31% |
| 2012 | -4.72 Million USD | 46.81% |
| 2011 | -9.79 Million USD | 5.46% |
| 2010 | -10.38 Million USD | -33.39% |
| 2009 | -7.91 Million USD | -696.4% |
| 2008 | -2.24 Million USD | -87.54% |
| 2007 | 10.47 Million USD | -38.94% |
| 2006 | -2.65 Million USD | -4.63% |
| 2005 | 17.97 Million USD | 152.8% |
| 2004 | 5.15 Million USD | 26.84% |
| 2003 | 5.6 Million USD | 227.51% |
| 2002 | 1.71 Million USD | -31.79% |
| 2001 | 2.51 Million USD | 197.39% |
| 2000 | 844 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -25.75 Million USD | 57.16% |
| 2024 Q2 | -18.62 Million USD | -25.3% |
| 2023 FY | - USD | -282.92% |
| 2023 Q3 | -35.94 Million USD | -35.48% |
| 2023 Q1 | -20.39 Million USD | -408.12% |
| 2023 Q2 | -26.53 Million USD | -30.08% |
| 2023 Q4 | -39.2 Million USD | -9.07% |
| 2022 Q4 | -4.01 Million USD | 54.87% |
| 2022 FY | - USD | -65617.24% |
| 2022 Q1 | -13.7 Million USD | -483.89% |
| 2022 Q2 | -9.86 Million USD | 28.05% |
| 2022 Q3 | -8.89 Million USD | 9.8% |
| 2021 Q1 | 1.47 Million USD | -17.24% |
| 2021 FY | - USD | 100.27% |
| 2021 Q3 | 147 Thousand USD | -93.32% |
| 2021 Q4 | -2.34 Million USD | -1696.6% |
| 2021 Q2 | 2.19 Million USD | 49.19% |
| 2020 FY | - USD | -103.82% |
| 2020 Q1 | -11.76 Million USD | -652.01% |
| 2020 Q2 | -10.57 Million USD | 10.14% |
| 2020 Q4 | 1.78 Million USD | 304.71% |
| 2020 Q3 | -870 Thousand USD | 91.77% |
| 2019 Q2 | 703 Thousand USD | 109.23% |
| 2019 Q1 | -7.61 Million USD | -48.44% |
| 2019 Q4 | -1.56 Million USD | 23.28% |
| 2019 Q3 | -2.04 Million USD | -390.18% |
| 2019 FY | - USD | 13.68% |
| 2018 Q3 | -693 Thousand USD | 62.84% |
| 2018 Q1 | -4.49 Million USD | -193.47% |
| 2018 Q2 | -1.86 Million USD | 58.51% |
| 2018 FY | - USD | -397.73% |
| 2018 Q4 | -5.13 Million USD | -640.26% |
| 2017 Q2 | 1.97 Million USD | 269.44% |
| 2017 Q4 | 4.8 Million USD | 415.14% |
| 2017 Q3 | -1.52 Million USD | -177.3% |
| 2017 FY | - USD | 21.1% |
| 2017 Q1 | -1.16 Million USD | -124.82% |
| 2016 Q1 | -1.93 Million USD | -185.03% |
| 2016 Q2 | -1.17 Million USD | 39.31% |
| 2016 Q4 | 4.69 Million USD | 162.53% |
| 2016 Q3 | 1.78 Million USD | 252.56% |
| 2016 FY | - USD | 201.32% |
| 2015 Q4 | 2.27 Million USD | 427.23% |
| 2015 FY | - USD | 64.07% |
| 2015 Q3 | -694 Thousand USD | 57.61% |
| 2015 Q2 | -1.63 Million USD | 50.02% |
| 2015 Q1 | -3.27 Million USD | -163.05% |
| 2014 Q1 | -3.32 Million USD | -36811.11% |
| 2014 Q2 | -2.5 Million USD | 24.56% |
| 2014 Q3 | -2.21 Million USD | 11.81% |
| 2014 Q4 | -1.24 Million USD | 43.67% |
| 2014 FY | - USD | -134.89% |
| 2013 Q1 | -1.99 Million USD | -234.14% |
| 2013 FY | - USD | 24.31% |
| 2013 Q4 | -9000.00 USD | 99.45% |
| 2013 Q3 | -1.65 Million USD | -455.56% |
| 2013 Q2 | -297 Thousand USD | 85.12% |
| 2012 Q3 | -690 Thousand USD | 37.04% |
| 2012 FY | - USD | 46.81% |
| 2012 Q1 | -4.92 Million USD | -528.74% |
| 2012 Q2 | -1.09 Million USD | 77.74% |
| 2012 Q4 | 1.48 Million USD | 315.65% |
| 2011 Q3 | -2.41 Million USD | 11.79% |
| 2011 Q2 | -2.73 Million USD | 29.33% |
| 2011 Q1 | -3.87 Million USD | -178.05% |
| 2011 FY | - USD | 5.46% |
| 2011 Q4 | -783 Thousand USD | 67.59% |
| 2010 Q4 | -1.39 Million USD | 59.29% |
| 2010 FY | - USD | -33.39% |
| 2010 Q1 | -1.94 Million USD | -775.23% |
| 2010 Q2 | -3.63 Million USD | -87.29% |
| 2010 Q3 | -3.42 Million USD | 5.91% |
| 2009 Q1 | -1.8 Million USD | -273.44% |
| 2009 Q2 | -4.42 Million USD | -144.44% |
| 2009 Q4 | -222 Thousand USD | 84.64% |
| 2009 Q3 | -1.44 Million USD | 67.32% |
| 2009 FY | - USD | -696.4% |
| 2008 Q1 | -1.45 Million USD | -147.11% |
| 2008 Q3 | 1.39 Million USD | 330.96% |
| 2008 Q4 | 1.04 Million USD | -25.07% |
| 2008 FY | - USD | -87.54% |
| 2008 Q2 | 323 Thousand USD | 122.23% |
| 2007 Q3 | 3.33 Million USD | 53.12% |
| 2007 Q4 | 3.08 Million USD | -7.53% |
| 2007 FY | - USD | -38.94% |
| 2007 Q1 | 1.87 Million USD | -79.15% |
| 2007 Q2 | 2.17 Million USD | 16.22% |
| 2006 Q1 | 917 Thousand USD | -87.19% |
| 2006 Q4 | 8.98 Million USD | 99.47% |
| 2006 Q3 | 4.5 Million USD | 64.69% |
| 2006 Q2 | 2.73 Million USD | 198.36% |
| 2006 FY | - USD | -4.63% |
| 2005 FY | - USD | 152.8% |
| 2005 Q4 | 7.15 Million USD | 38.82% |
| 2005 Q3 | 5.15 Million USD | 50.35% |
| 2005 Q2 | 3.43 Million USD | 53.61% |
| 2005 Q1 | 2.23 Million USD | -48.14% |
| 2004 FY | - USD | 26.84% |
| 2004 Q3 | 1.46 Million USD | 14.15% |
| 2004 Q1 | 626 Thousand USD | -73.96% |
| 2004 Q2 | 1.28 Million USD | 105.43% |
| 2004 Q4 | 4.3 Million USD | 193.32% |
| 2003 Q4 | 2.4 Million USD | 20.56% |
| 2003 Q2 | 1.13 Million USD | 0.0% |
| 2003 FY | - USD | 227.51% |
| 2003 Q3 | 1.99 Million USD | 75.07% |
| 2002 FY | - USD | -31.79% |
| 2001 FY | - USD | 197.39% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -174.379% |
| BrainsWay Ltd. | -2.31 Million USD | -5809.174% |
| Cerus Corporation | -26.53 Million USD | -414.625% |
| Envoy Medical, Inc. | -18.23 Million USD | -648.772% |
| electroCore, Inc. | -17.76 Million USD | -668.925% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -1027.951% |
| IceCure Medical Ltd | -15.25 Million USD | -795.306% |
| Inogen, Inc. | -45.67 Million USD | -198.958% |
| OrthoPediatrics Corp. | -8.38 Million USD | -1529.412% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -174.489% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -710.177% |
| MaxCyte, Inc. | -44.12 Million USD | -209.466% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -1061.63% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2299.157% |
| Orthofix Medical Inc. | -86.98 Million USD | -56.994% |
| PAVmed Inc | -75.74 Million USD | -80.298% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -154.029% |
| RxSight, Inc. | -41.03 Million USD | -232.775% |
| Sight Sciences, Inc. | -49.41 Million USD | -176.355% |
| SI-BONE, Inc. | -34.44 Million USD | -296.45% |
| TELA Bio, Inc. | -40.63 Million USD | -236.084% |
| Treace Medical Concepts, Inc. | -39 Million USD | -250.085% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -718.957% |
| Acutus Medical, Inc. | -13.48 Million USD | -912.538% |
| Talis Biomedical Corporation | -66.04 Million USD | -106.77% |
| Spectral AI, Inc. | -12.26 Million USD | -1013.693% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -186.333% |
| CVRx, Inc. | -38.73 Million USD | -252.588% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -3770.777% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -1201.264% |
| Bioventus Inc. | -23.07 Million USD | -491.942% |
| Venus Concept Inc. | -26.11 Million USD | -422.962% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -134.246% |
| LivaNova PLC | 39.01 Million USD | 450.013% |
| 908 Devices Inc. | -34.02 Million USD | -301.355% |
| Alphatec Holdings, Inc. | -110.59 Million USD | -23.482% |
| Nemaura Medical Inc. | -7.28 Million USD | -1774.021% |
| NeuroPace, Inc. | -22.83 Million USD | -498.06% |
| LENSAR, Inc. | -8.71 Million USD | -1467.145% |
| Apyx Medical Corporation | -18.11 Million USD | -653.981% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -3940.266% |
| BioSig Technologies, Inc. | -28.15 Million USD | -385.102% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 5527.703% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -550.631% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 135.603% |
| Axonics, Inc. | 7.77 Million USD | 1856.412% |
| Outset Medical, Inc. | -153.78 Million USD | 11.202% |
| IRIDEX Corporation | -7.44 Million USD | -1733.526% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | -39.213% |
| IRadimed Corporation | 20.8 Million USD | 756.523% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -1593.885% |
| INVO Bioscience, Inc. | -6.88 Million USD | -1884.892% |
| Telesis Bio, Inc. | -40.49 Million USD | -237.246% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 472.334% |
| Varex Imaging Corporation | 67.2 Million USD | 303.216% |
| Quipt Home Medical Corp. | 44.07 Million USD | 409.866% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -1156.311% |
| Pulmonx Corporation | -55.09 Million USD | -147.878% |
| Dynatronics Corporation | -976 Thousand USD | -13891.791% |
| Modular Medical, Inc. | -17.1 Million USD | -698.462% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -842.775% |
| Semler Scientific, Inc. | 23.58 Million USD | 678.918% |
| InMode Ltd. | 196.28 Million USD | 169.574% |
| Bruker Corporation | 599 Million USD | 122.798% |
| Cytosorbents Corporation | -28.81 Million USD | -373.992% |
| DexCom, Inc. | 916.7 Million USD | 114.897% |
| Align Technology, Inc. | 799.03 Million USD | 117.091% |
| Viveve Medical, Inc. | -20.61 Million USD | -562.371% |
| ZimVie Inc. | 91.07 Million USD | 249.947% |
| Movano Inc. | -29.12 Million USD | -368.879% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -2998.027% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2299.157% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -3770.777% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 29.845% |
| Profound Medical Corp. | -27.12 Million USD | -403.479% |
| Insulet Corporation | 323.6 Million USD | 142.201% |
| enVVeno Medical Corporation | -25.01 Million USD | -445.851% |
| Surmodics, Inc. | 1.18 Million USD | 11595.034% |
| iCAD, Inc. | -6.56 Million USD | -1980.137% |
| Nuwellis, Inc. | -16.35 Million USD | -734.929% |
| Biotricity, Inc. | -8.82 Million USD | -1446.86% |
| iRhythm Technologies, Inc. | -96.86 Million USD | -40.985% |
| Aethlon Medical, Inc. | -11.84 Million USD | -1052.499% |
| InspireMD, Inc. | -20.91 Million USD | -553.058% |
| PAVmed Inc. | -75.74 Million USD | -80.298% |
| BIOLASE, Inc. | -15.13 Million USD | -802.048% |
| Beyond Air, Inc. | -59.03 Million USD | -131.338% |
| FONAR Corporation | 28.25 Million USD | 583.375% |
| AxoGen, Inc. | -13.32 Million USD | -924.617% |
| Vivani Medical, Inc. | -26.6 Million USD | -413.233% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 656.461% |
| Inari Medical, Inc. | 7.11 Million USD | 2019.879% |
| UFP Technologies, Inc. | 72.74 Million USD | 287.731% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -3933.362% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -2118.342% |
| Tenon Medical, Inc. | -15.52 Million USD | -779.45% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -794.543% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -229.255% |
| AdaptHealth Corp. | -171.09 Million USD | 20.182% |
| Sintx Technologies, Inc. | -6.6 Million USD | -1969.106% |
| NanoVibronix, Inc. | -3.43 Million USD | -3875.575% |
| Quanterix Corporation | -38.08 Million USD | -258.541% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -1156.311% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 455303.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 50.75% |
| TransMedics Group, Inc. | -7.6 Million USD | -1696.146% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -527.434% |
| NeuroMetrix, Inc. | -7.09 Million USD | -1824.53% |
| Hyperfine, Inc. | -47.06 Million USD | -190.179% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -134.21% |
| Biomerica, Inc. | -5.99 Million USD | -2178.675% |
| Bone Biologics Corporation | 479.57 Thousand USD | 28575.599% |
| AVITA Medical, Inc. | -39.56 Million USD | -245.132% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -1388.739% |
| Silk Road Medical, Inc | -45.08 Million USD | -202.93% |